Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Therapy of Nivolumab and Adoptive T Cell Therapy in Metastatic Melanoma Patients: Pilot Study Phase I/II

NCT03374839 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT03374839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03374839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Therapy of Nivolumab and Adoptive T Cell Therapy in Metastatic Melanoma Patients: Pilot Study Phase I/II
Lead sponsor
Nantes University Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
February 12, 2018
Completion date
January 31, 2024
Enrollment
11 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma